Skip to main content

Celecoxib

NDC 71209-054 · Cadila Pharmaceuticals Limited

Generic nameCelecoxib
Dosage formCAPSULE
RouteORAL
Active ingredient(s)CELECOXIB
Strength50 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

71209-054-03 — 60 CAPSULE in 1 BOTTLE (71209-054-03)

71209-054-11 — 1000 CAPSULE in 1 BOTTLE (71209-054-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-4009 — Celecoxib, 70518-4175 — Celecoxib, 70518-4508 — Celecoxib, 70518-4619 — Celecoxib, 70518-4726 — Celecoxib, 71205-020 — Celecoxib, 71205-027 — celecoxib, 71205-055 — Celecoxib, 71205-439 — celecoxib, 71205-664 — Celecoxib, 71209-055 — Celecoxib, 71209-056 — Celecoxib, 71209-057 — Celecoxib, 71335-0292 — Celecoxib, 71335-0868 — celecoxib, 71335-0936 — celecoxib, 71335-1066 — Celecoxib, 71335-1804 — Celecoxib, 71335-2019 — CELECOXIB, 71335-2220 — Celecoxib, +213 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels